- Tytuł:
- A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-alpha, in patients with corticosteroid-dependent Crohn's disease.
- Autorzy:
- Źródło:
- Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2005 Feb 15; Vol. 21 (4), pp. 373-84.
- Typ publikacji:
- Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
- MeSH Terms:
-
Anti-Inflammatory Agents, Non-Steroidal/*therapeutic use
Antibodies, Monoclonal/*therapeutic use
Crohn Disease/*drug therapy
Gastrointestinal Agents/*therapeutic use
Adult ; Anti-Inflammatory Agents/administration & dosage ; Anti-Inflammatory Agents/adverse effects ; Antibodies, Monoclonal/adverse effects ; Budesonide/administration & dosage ; Crohn Disease/pathology ; Double-Blind Method ; Drug Administration Schedule ; Female ; Humans ; Male ; Middle Aged ; Prednisolone/administration & dosage ; Quality of Life ; Severity of Illness Index ; Treatment Outcome ; Tumor Necrosis Factor-alpha/antagonists & inhibitors
Czasopismo naukowe